Tetra Bio-Pharma Starts Phase I Clinical Study of Smoked Cannabis.

Tetra Bio-Pharma (CSE: TBP) (CSE: TBP.CN), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce that Health Canada has approved its Phase I clinical study of smoked cannabis.

Valens GroWorks Enters Into $1.2m Loan Repayment Agreements

 Valens GroWorks Corp. (CSE: VGW) together with its subsidiary is pleased to announce its engagement under a 5-year, renewable, Professional Services Agreement  with Arizona-based marijuana cultivation and medicinal dispensary business MKHS.

InMed's Pharmaceuticals Inc. 2017 Prospects

InMed Pharmaceuticals Inc. (CSE:IN, OTCQB:IMLFF) is a pre-clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid-based therapies to treat human diseases with high unmet medical needs.

Acquisitions on the Rise as Companies Increase Revenue

The global marijuana industry continues to develop at an impressive pace, driven by new developments in the field of cannabis-based pharmaceutics.

As a result, M&A activity in the market is heading toward exponential growth as well.


Mining for Marijuana in Canada

Spirit Gold (SG.v) once an exploration stage company engaged in acquiring, exploring and evaluating mineral resource has turned their attention to Marijuana. Spirit Gold Entered Into Definitive Agreement to Acquire Northern Lights Marijuana Company.

Investing In A Different Kind Of Oil

In Canada, medical marijuana patients have the option to get their medication in dried form, as a concentrated oil or even fresh. Right now there are 38 approved licensed producers of medical marijuana of which only 22 produce oil. So why should this matter to Investors?

Rising India Inc. Enters the $6.5 Billion Cannabis Industry

Rising India Inc. (OTC: RSII) announced that the company is targeting opportunities in the cannabis industry. The company is in active negotiations to reach a Letter of Intent with business operators that are currently active in the cannabis industry.

Healthcare Technology Heavily Influencing the Legal Cannabis Patient Industry

Healthcare Technology Heavily Influencing the Legal Cannabis Patient Industry 07/02/2017 14:30 PALM BEACH, Florida , February 7, 2017 /PRNewswire/ -- The injection of modern technology into the developing world of cannabis and legal medical marijuana is helping the industry climb to new heights and increase engagement with consumers, especially when it comes to cannabis patients in the medical facet of the industry.

Disruptive Technology: Here’s The Future $PKG $WEED $MYM $PTNYF

Ding Dong: Here’s Your Pot. In the world of new and disruptive technologies, there are a few ideas that just make a lot of sense to everyone. And sure enough, several have become overnight sensations creating unimaginable wealth (especially for early investors), while changing the landscape completely. The funny thing is, they often don’t rely on infrastructure or conventional business models at all.

Invictus MD announces binding LOI to acquire 100% of a Late Stage Applicant under Health Canada’s ACMPR

INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that on February 6, 2017 it had entered into a binding letter of intent (“LOI”) for an option to acquire 100% (the “Option”) of the outstanding shares of a Late Stage Applicant (the “OptionCo”) under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) from its current shareholders (the “Vendors”).

Ex-Medical Marijuana Officials Charged for Illegal Shipment


ST. PAUL, Minn. (AP) — Prosecutors in Minnesota filed felony charges Monday against two former officials from one of the state’s licensed medical marijuana manufacturers for allegedly shipping marijuana oil to a subsidiary facility in New York.